Cardiovascular Monitoring of Children and Adolescents Receiving Psychotropic Drugs: A Statement for Healthcare Professionals From the Committee on Congenital Cardiac Defects, Council on Cardiovascular Disease in the Young, American Heart Association
Howard Gutgesell;Dianne Atkins;Robyn Barst;Marcia Buck;Wayne Franklin;Richard Humes;Richard Ringel;Robert Shaddy;Kathryn A. Taubert;
This statement was approved by the American Heart Association Science Advisory and Coordinating Committee in November 1998. A single reprint is available by calling 800-242-8721 (US only) or writing the American Heart Association, Public Information, 7272 Greenville Avenue, Dallas, TX 75231-4596. Ask for reprint No. 71-0159. To purchase additional reprints: up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 214-706-1466, fax 214-691-6342, or e-mail firstname.lastname@example.org. To make photocopies for personal or educational use, call the Copyright Clearance Center, 978-750-8400.(Circulation. 1999;99:979-982.).